SAM, Linklaters, JSA Act On Biocon’s $460 Million QIP Biopharamaceuticals January 19, 2026 Capital Markets
IndusLaw Advised BRLMs On Sammaan Capital’s QIP That Raised $150 Million Banking & Financial Services February 4, 2025 Capital Markets
